The NASS Podcast

Moderator Jayesh Vallabh, MD, interviews authors Rhett MacNeille, MD, and Olumide Danisa, MD, of Loma Linda University in California about their recent SpineLine article, "Hip-Spine Syndrome: Avoiding the Pitfalls." Access the article here . Disclosures: Danisa, Olumide A.: Board of Directors: Musculoskeletal Transplantation Foundation (B, Paid directly to institution/employer); Consulting: Spinea...

How has the COVID-19 pandemic impacted your practice? What changed for you and your care team during social distancing phase? What changed for you and your care team after social distancing requirements lapsed? Join Section on Spine Oncology members John H. Shin, MD, Iliya Laufer, MD and Jacob Buchowski, MD, MS as they discuss their experiences over the past 18 months with moderator Matthew Goodwi...

When signals are lost during surgical correction of complex spinal deformities, one available tool for localizing the site of injury is the dynamic spinal cord mapping technique. This valuable technique has gained popularity largely due to Dr. Lenke’s work in popularizing it for this purpose. In this episode, Dr. Lenke is interviewed about how he uses this technique, what information it provides,...

Authors Akhil Chhatre, MD, and Laryssa Richards, DO, discuss quality improvement measures their team has implemented at Johns Hopkins with moderator Renee Rosati, DO, in this episode of Spotlight on SpineLine. Access the article here . Disclosures: Chhatre, Akhil : Nothing to Disclose Rosati , Renee Michelle: Nothing to Disclose     Richards, Laryssa: Nothing to Disclose Key: A: $10...

Use of neuromonitoring in cervical spine surgery varies significantly across the US and around the world. In some regions, multimodality neuromonitoring is used routinely for all procedures. In other regions, it’s rarely used at all. In this episode, Dr. Todd Albert is interviewed for his perspective as an orthopedic spine surgeon. Disclosures: Albert, Todd J.: Board of Directors: American Orthopa...

Moderator Jayesh Vallabh, MD, chats with NASS President Eeric Truumees, MD, about Dr. Truumees recent column in SpineLine, which outlines the differences between NASS 3 and NASS6. Dr. Truumees talks about the importance of being involved in advocacy and how your dollars are being allocated. Disclosures: Truumees, Eeric: Board of Directors: Seton Family of Doctors (None); Other Office: AAOS  (...

In this era of evidence-based medicine, administrative claims databases are of interest because they allow us to evaluate complex questions with large numbers; but, they also have their drawbacks. Numerous studies have used these databases to examine neuromonitoring trends in the US. What have we learned from these studies, and where should future studies focus? In this episode, Section on IONM Me...

Moderator Erik Westerlund, MD discusses the 2020 JAMA article, "Effect of spinal manipulative and mobilization therapies in young adults with mild to moderate chronic low back pain: a randomized clinical trial" with Literature Review authors Ryan L. McLean, BS and Jonathan N. Grauer, MD. Access the article here . Disclosures: Grauer, Jonathan N.: Board of Directors: LSRS (Nonfinancial, committee/b...

Who are the different neuromonitoring societies, what role(s) do they play in patient care, where are they focusing their efforts, and what opportunities are there for inter-society collaboration? In this episode, NASS IONM Section Co-Chair, Dr. Richard Vogel, is interviewed in his role as Past-President of the American Society of Neurophysiological Monitoring (ASNM). Disclosures: Doan, Adam: Othe...

How many surgeries are monitored in the US each year? What portion are spine? Is use of IONM increasing or decreasing? What major trends do we see in the use of IONM in spine surgery, and what can we expect in the future? This episode hosted by Section on Intraoperative Neurophysiological Monitoring (IONM) Co-Chairs Dr. Rich Vogel and Dr. Adam Doan will answer all of these questions and more! Disc...

Featuring: Moderator Alex Michael, MD and Author James Reynolds, MD James Reynolds, MD, co-chair of NASS' Patient Safety Committee, discusses Preventing Blood Loss in Spine Surgery with Tranexamic Acid. Reducing blood loss during spine surgery is one of the many responsibilities of spine surgeons to keep patients safe. Dr. Reynolds addresses this and more in the latest episode discussing an articl...

Featuring: Moderator Renee Rosati, DO and Author David O'Brien, Jr., MD. NASS Treasurer David O'Brien, Jr., MD, discusses new Interventional Spine & Musculoskeletal Medicine Fellowships and the opportunities they will afford young physicians. Dr. O'Brien touches on NASS completing its inaugural ISMM fellowships with a 100% match, and more in this podcast with moderator Renee Rosati, DO. Access...

Featuring: Jin Sun Kim, MD and Michael Y. Wang, MD Disclosures: Kim, Jin Sun: Stock Ownership: Innovasive (1%); Consulting: Richard Wolf (Travel Expense Reimbursement), Elliquence (Travel Expense Reimbursement); Scientific Advisory Board: Innovasive (Nonfinancial); Grants: AOSpine (A). Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (1%), Medical Device Partners (1%); Co...

Featuring: Michael Y. Wang, MD and Daniel K. Resnick, MD Disclosures: Resnick, Daniel: Scientific Advisory Board: NIDUS (None). Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (1%), Medical Device Partners (1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A). Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25...

Moderator Douglas Pahl, MD, interviews authors Alex Mierke, MD, and Omar Ramos, MD, about their article titled, "Stem Cell Therapies in the Treatment of Disc-Related Low Back Pain." Drs. Mierke and Ramos discuss what is already known about stem cell therapies and what still may lie ahead in this ever-changing medical landscape. Access the article here . Disclosures: Mierke, Alex : Nothing to Discl...

Featuring: Joseph S. Butler, PhD, FRCS and Arjun S. Sebastian, MD Disclosures: Butler, Joseph S.: Nothing to Disclose (Sep 26, 2019).   Sebastian, Arjun S.: Nothing to Disclose (Feb 04, 2019) Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: Mark M. Mikhael, MD; Deepak Reddy, MD; Bradley Saitta, MD; Nick Shamie, MD Disclosures: Mikhael, Mark M.: Consulting: Clariance Spine (B), GS Medical (B). Reddy, Deepak: Nothing to Disclose. Saitta, Bradley: Nothing to Disclose. Shamie, Nick: Royalties: Seaspine (B); Stock Ownership: SI Bone (100000 Shares, 1%), Vertiflex (200000 Shares, 1%); Consulting: Stryker (Financial, 0), Seaspine...

Featuring: Mark M. Mikhael, MD; Deepak Reddy, MD; Bradley Saitta, MD; Nick Shamie, MD Disclosures: Mikhael, Mark M.: Consulting: Clariance Spine (B), GS Medical (B).  Reddy, Deepak: Nothing to Disclose.   Saitta, Bradley: Nothing to Disclose. Shamie, Nick: Royalties: Seaspine (B); Stock Ownership: SI Bone (100000 Shares, 1%), Vertiflex (200000 Shares, 1%); Consulting: Stryker (Financial,...

Featuring: Zoher Ghogawala, MD; Han Jo Kim, MD; Khoi D. Than, MD Disclosures: Ghogawala, Zoher: Board of Directors: Cervical Spine Research Society (Research Committee Chair, Registry Director), GN2.0-Nidus (66%), Joint Spine Section - AANS-CNS (Chair).   Kim, Han Jo: Board of Directors: AOSpine (B); Fellowship Support: AOSpine (D, Paid directly to institution/employer); Research Support (Sta...

Featuring: Evan K. Johnson, PT, DPT, OCS and Rick J. Placide, MD, PT Disclosures: Johnson, Evan K. : Nothing to Disclose.   Placide, Rick J. : Nothing to Disclose. Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

Featuring: Sandeep N. Gidvani, MD and Nickul Jain, MD Disclosures: Gidvani, Sandeep N.: Consulting: Xenco Medical (B), SeaSpine (None), Spinal Balance (None), SI-BONE (None), NuVasive (None).   Jain, Nickul: Consulting: Spineart (Future Compensation Expected); Research Support (Staff and/or materials): Globus Medical (Nonfinancial). Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D...

Featuring: Sandeep N. Gidvani, MD and Paul R. Gause, MD Disclosures: Gause, Paul R. : Speaking and/or Teaching Arrangements: Medtronic (C).  Gidvani, Sandeep N. : Consulting: Xenco Medical (B), SeaSpine (None), Spinal Balance (None), SI-BONE (None), NuVasive (None).   Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000...

Featuring: E. Kano Mayer, MD; Eeric Truumees, MD; Mark Cuccuzella, MD Disclosures: Cuccuzella, Mark: Nothing to Disclose. Mayer, E. Kano: Stock Ownership: Infinite Orthopedics (1%); Private Investments: Lanai Health Solutions (30%); Speaking and/or Teaching Arrangements: North America Spine Society (B); Trips/Travel: NASS (B).   Truumees, Eeric: Trips/Travel: AAOS (Travel Expense Reimbursemen...

Featuring: Zorica Buser, PhD and Mark Erwin, DC, PhD Disclosures: Buser, Zorica: Consulting: AOSpine (B, Outside 12-Month Requirement), Xenco Medical (B, Outside 12-Month Requirement); Research Support (Investigator Salary): SeaSpine (F, Paid directly to institution/employer); Research Support (Staff and/or materials): Next Science (F, Paid directly to institution/employer), SeaSpine (F, Paid dire...

Featuring: Matthew L. Goodwin, MD, PHD (Washington University), Dan Sciubba, MD (Johns Hopkins), and Joe Schwab, MD, MS (Harvard/Massachusetts General Hospital) Use of bone cement in the spine has been marred by early controversy, including debate over kyphoplasty/vertebroplasty and whether use of bone cement in spine surgery was safe or effective.  Now with recent publications reviewing almo...